Combination Therapy in Multiple Sclerosis
ID Number 02-0526
Principal Investigator(s)Fred Lublin
Department(s) or Division(s)
Neurology
Description
The purpose of the study is to determine whether the combination of interferon beta 1-a (Avonex®) and glatiramer acetate (Copaxone®) is an effective therapy for Relapsing-Remitting form of Multiple Sclerosis (MS).
Contact Information
Tarah Gustafson Herrmann
(212) 241-4264
tarah.gustafson@mssm.edu
Recruiting Patients: No